Oncotarget is a publication being released twice a week that tackles everything about rare diseases and how the scientific community is doing everything that they can to discover their cure. Oncotarget primarily publishes information about cancer in the past, but the scientists have also agreed to include articles about other fatal and incurable diseases. Oncotarget can be accessed online, and it is considered as the first online medical journal that allows the community, especially a team of scientists, to review every article published making sure that it is reliable and scientifically accurate. The current editors in chief of Oncotarget are Mikhail Blagosklonny and Andrei V. Gudkov, two of the leading oncologists at the Roswell Park Cancer Institute. Follow Oncotarget on Linkedin.
For others, it seems like Oncotarget is a sophisticated website that cannot be used without advance knowledge in computer systems, but according to Mikhail Blagosklonny and Andrei V. Gudkov, the online medical journal is very easy to use. According to the editors in chief of Oncotarget, scientists can access the website anytime they wish, uploading all of the files that they have regarding the research on a particular disease. Before being published, the research will be forwarded to a team of reviewers who are scientists themselves, and they are the ones who would review whether the article can be published or not. Once the article made it through the panel, it would be available to be viewed on the website. Listen to an audio podcast of Oncotarget on Itunes.
Many scientists found Oncotarget to be useful, because of the unlimited amount of information that they are receiving. According to some of the leading research facilities around the world, Oncotarget helped them develop an alternative treatment for cancer and other fatal and rare diseases because of the suggestions and recommendations that they are reading from the online medical journal. One of these research facilities claimed that they had developed an apparatus which can detect cancerous tumors and cells, and the equipment can distinguish them from healthy cells. It results in the complete annihilation of the cancer cells, and it is now viewed as a possible cure in the future. Oncotarget publishes articles similar articles for the world to see.